Trials / Completed
CompletedNCT02302885
Healthy Human Control Blood Collection for Validation of Biomarker Assay
Human Blood Collection to Serve as Negative Control for Validation of Circulating Tumor Cell Assay
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 43 (actual)
- Sponsor
- Abramson Cancer Center at Penn Medicine · Academic / Other
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
Human blood will be collected to serve as control in validating clinical studies studying the detection and levels of circulating tumor cells and microvesicles in cancer patients. Targeted population is cancer-free 18-60 year old men and women. Volunteer selection will rely upon a short health questionnaire. About 20 mL blood will be collected from volunteers up to 20 different timepoints. The Procedure involves minimal risk of harm (eg discomfort, bruising) to the volunteer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Blood collection | Blood Collection |
Timeline
- Start date
- 2014-11-01
- Primary completion
- 2018-12-01
- Completion
- 2019-04-30
- First posted
- 2014-11-27
- Last updated
- 2026-01-29
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02302885. Inclusion in this directory is not an endorsement.